Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Herspiegel is a leading provider of commercialization strategy and implementation services for pharmaceutical, biotech, and medical device companies. The firm specializes in commercial launch readiness, market access planning, medical affairs support, marketing strategy, patient services implementation, and contract commercial services. It has supported over 50 product launches across diverse therapeutic areas including oncology, rare disease, CNS disorders, metabolic diseases, vaccines and more. In April 2025 it expanded its global reach by acquiring FIECON to strengthen its health economics and market access capabilities in Europe.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Herspiegel.